Skip to main content
SpringerLink
Log in

Abacavir: inconsistent results for MI risk

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Lundgren J, Neuhaus J, Babiker A, Cooper D, Duprez D, El-Sadr W, Emery S, Gordin F, Kowalska J, Phillips A, Prineas R, Reiss P, Sabin C, Tracy R, Weber R, Grund B, Neaton J, SMART/INSIGHT and D:A:D Study Groups.Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the SMART study. 17th International AIDS Conference: abstr. THAB0305, 3 Aug 2008. Available from: URL: http://www.aids2008.org

  2. Cutrell A, Hernandez J, Yeo J, Brothers C, Burkle W, Spreen W.Is abacavir-containing combination antiretroviral therapy associated with myocardial infarction? No association identified in pooled summary of 54 clinical trials. 17th International AIDS Conference: abstr. WEAB0106, 3 Aug 2008. Available from: URL: http://www.aids2008.org

  3. GlaxoSmithKline.Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy. Media Release: 6 Aug 2008. Available from: URL: http://www.gsk.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abacavir: inconsistent results for MI risk. React. Wkly. 1216, 2 (2008). https://doi.org/10.2165/00128415-200812160-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812160-00002

Keywords

Search

Navigation